Five genetically distinct human rotavirus (HRV) gene 4 groups have been described on the basis ofcomparative nucleotide sequencing and the predicted amino acid sequences, and at least four of them represent distinct VP4 16 strains by reverse transcription and PCR amplification of HRV dsRNA in the presence of alternate type-specific primer pairs. For direct gene 4 typing of HRV in stool samples, we developed a method to extract rotavirus dsRNA from stool specimens by using glass powder. Our results suggest that gene 4 typing will be useful in providing more a complete characterization of HRV strains of epidemiologic or vaccine-related interest.
The importance of group A human rotaviruses (HRVs) in diarrheal illnesses of infants and young children has resulted in efforts to develop a vaccine (7) and to characterize the antigens involved in immunity. At least seven serotypes of HRV have been described on the basis of cross-neutralization studies with hyperimmune sera containing neutralizing antibodies to both the VP7 and VP4 polypeptides (15, 30) . Genetic and molecular experiments and studies with neutralizing, serotype-specific monoclonal antibodies (MAbs) have identified VP7 as a major type-specific neutralization protein (15) . The availability of MAbs that specifically bind the VP7 polypeptides of HRV serotypes 1 to 4 led to the development of enzyme immunoassays (EIAs) for the rapid serotyping of HRV in stool samples (31) . As a result, antigenic diversity in the VP7 polypeptide of HRV is well defined. These methods have been used in epidemiologic surveys of circulating HRVs to demonstrate that serotypes 1 to 4 are found worldwide, whereas the distribution serotypes 8 and 9 and the newly described serotype 12 have not been studied extensively (15, 30, 32) .
Antigenic diversity within the VP4 neutralization antigen has not been clearly defined. The observation that rotaviruses isolated from humans or animals may possess dual serotype specificities and that the second specificity resides on VP4 suggests that a complete antigenic characterization of rotaviruses should include VP4 as well as VP7 (13, 25 strains on the basis of sequence and predicted amino acid conservation in strains that possess the same type and extensive diversity in strains with a different type (9) . Strains that possess one or the other of the gene 4 types (referred to as P types 1 to 5) have been designated as belonging to VP4 genetic groups 1 to 5 (9) . P type 1 is present in symptomatic strains of VP7 serotypes 1, 3, 4, and 9 (designated VP4 genetic group 1), P type 2 is present in members of VP7 serotype 2 (genetic group 2), P type 3 is present in strains with VP7 serotype 1 to 4 specificities (so far isolated only from newborn infants excreting rotavirus asymptomatically) (genetic group 3), P type 4 is present in the VP7 serotype 1 strain K8 (genetic group 4) (29), and P type 5 is present in the VP7 serotype 8 strain 69M (genetic group 5) (27) . Recently, experimental evidence that members of VP4 genetic groups 1 to 4 can be divided into three antigenic groups, tentatively designated serotypes, and one subtype has been presented. The evidence was obtained on the basis of cross-neutralization tests with antisera to baculovirus-expressed VP4 polypeptides of prototype strains KU (group 1), DS1 (group 2), 1076 (group 3), and K8 (group 4) (10) . Furthermore, all members of the same genetic group fell within the same antigenic group. Taken together, these results suggest that methods for identifying VP4 genetic groups at the nucleic acid level would be a valid proxy method to assess the diversity of gene 4 in circulating strains of HRV.
Recently, a hybridization method for identifying VP4 genetic groups has been described (17) . In the present study we report the development of a polymerase chain reaction (PCR) method to identify (or type) gene 4 types 1 to 4 and demonstrate that 16 Viruses. HRV strains were grown in MA104 cells and were purified by established methods (20) . Virus particle and nucleic acid concentrations were estimated from the relationship that purified virions suspended at 185 ,g of viral protein per ml contain a particle concentration of 2.1 x 1012/ml and a dsRNA concentration of 45 ptg/ml (23) . Viral protein was estimated by using the Bio-Rad assay (Richmond, Calif.).
Stool samples were obtained from collections previously sent to the Centers for Disease Control for analysis. Samples from the United States were from patients with gastroenteritis and were submitted by members of the Rotavirus Study Group (19) . Samples from Mexico and Costa Rica were also from patients with gastroenteritis or were from asymptomatic infants who secreted rotavirus and were submitted by G. Ruiz-Palacios and L. Mata for a collaborative serotyping project (32) . Venezuelan samples were from asymptomatic newborn infants (in neonatal hospital wards) who excreted rotavirus (17) . Samples for gene 4 typing were selected randomly from samples with known (G, VP7) serotypes, without regard to virus particle number.
Enzymes. Super-reverse transcriptase was from Molecular Genetics Resources (Tampa, Fla.), Taq and Amplitaq polymerases were from Perkin-Elmer Cetus (Norwalk, Conn.), and proteinase K was from Boehringer Mannheim (Indianapolis, Ind.).
Oligonucleotide primers. Primers were synthesized in the CDC Biotechnology Core Facility, Centers for Disease Control (Brian Holloway), and were used without purification. One pair of primers, con 3 and con 2, made against the KU virus gene 4 sequence (accession number M21014) ( Fig.  1) from the same group (9) . Five specific typing primers were prepared for gene 4 sequences of KU (primer iT-1, VP4 genetic group 1), RV5 (primer 2T-1, group 2), 1076 (primer 3T-1, group 3), K8 (primer 4T-1, group 4), and 69M (primer 5T-1, group 5) (primer 5T-1 was selected after the sequence of the strain 69M gene 4 was published and does not appear in Fig. 1 (16, 26) .
HRV dsRNA was extracted from stool specimens with a commercial glass powder preparation (RNAID or Geneclean II; Bio 101, Inc., La Jolla, Calif.) by using a modification of a published procedure (33 More recently, we have used a separate reverse transcription reaction in which the composition of the master mix was the same as that described above, except that the final volume was 49 [lI instead of 50 RI, Taq was left out, and mineral oil was not added. In this case, after denaturation of the RNA and addition of the master mix, the reverse transcription reaction was incubated for 60 min at 42°C in a circulating H20 bath. One microliter (1.9 U) of Taq was then added; this was followed by the addition of 100 p.l of mineral oil, and 30 cycles of PCR were carried out by using the same steps described above.
For the typing reaction (second amplification), 0.5 to 5.0 pul of the first amplification product (5 pA was used if there was no visible product and 0.5 p.l was used if there was a large amount of product) was mixed with 45 p.1 of reaction mixture in a final volume of 50 ,u1. When less than 5 (10) , suggesting that methods for identifying gene 4 types at the nucleic acid level are a valid proxy for studying the gene 4 diversity of circulating HRV strains.
Gene 4 typing by PCR. Analysis of 17 strains was carried out by two PCR amplifications. In the first, use of the primers con 2 and con 3 yielded intense dsDNA products of the predicted size (876 bp) for 14 of the 17 strains tested (Fig.  2) . With strain WI61 (Fig. 2, lane 8) , the absence of a product band was probably an artifact caused by extraneous material, perhaps cellular nucleic acids (after PAGE and silver staining, this preparation had a very high background) in the RNA preparation. Likewise, the high-molecular-weight bands observed in strain W161 and several other products (especially products from strains Wa and S2; Fig. 2 , lanes 1 and 10, respectively) may be artifacts of amplification of complex nucleic acids from cells, since they were not primer specific (also see Fig. 4 ) and were not observed after amplification of rotavirus RNAs extracted from stools. We confirmed that W161 dsRNA can be efficiently amplified with con 3 and con 2 by repeating this experiment with RNA from a partially purified virus preparation (data not shown). We also demonstrated, using other dsRNA preparations, that strain 1076 (Fig. 2, lane 12) The nature of the nonspecific but discrete products that we and others have observed at various intensities from experiment to experiment ( Fig. 2 and 3 ) (22) has not been characterized, but it probably results from mispriming events during amplification of complex nucleic acids (4). These products do not interfere with gene 4 typing.
When portions of the first amplification products were subjected to gene 4 typing PCR (Fig. 3) , we observed that only the eight reactions primed with dsDNA derived from HRV strains from VP4 genetic group 1 produced a dsDNA product of about 345 bp (Fig. 3, lanes 1 to 8) , the expected size of the product of con 3 and the genetic group 1-specific primer 1T-1 (Fig. 1) Fig. 3 , lanes 9 and 10), 267 bp (group 3; Fig. 3, lanes 11 to 14) , and 391 bp (group 4; Fig. 3, lane 15) , which are the predicted lengths of the products of amplification of these DNAs with con 3 and the group-specific primers 2T-1, 3T-1, and 4T-1, respectively. The typing band for strain WI61 (Fig. 3, lane 8) was not visible, while the band for strain 1076 (Fig. 3, lane 12) was faintly visible. We subsequently demonstrated, using other RNA preparations, that both can be reliably typed (data not shown). Strain AUl (Fig. 3, lane 16 ) was included in this experiment because the genes of this strain appear to be closely related to those of strain K8 (i.e., as a possible second member of VP4 genetic group 4), as determined by hybridization (5, 24) . Strain AUl gave a very weak band of 391 bp (comigrating with the product of strain K8) and several nonspecific bands, suggesting that it cannot be reliably typed. The reason that we cannot amplify strain AUl efficiently will not be known until the AUl gene 4 is sequenced. In the meantime, we are trying to obtain alternate K8-like and AUl-like isolates to determine whether this result is peculiar to the AUl isolate in our laboratory.
The failure of strain 69M to give a detectable product (Fig.  3, lane 17) was not surprising, since it possesses a unique gene 4 whose sequence was not published when we carried out this study. After its sequence was published, we designed two typing primers for 69M and have shown that (when they were used in a primer cocktail with con 3 and iT-1 to 4T-1) they produce 583-and 660-bp products from 69M DNA after the first amplification but not from comparable DNAs produced from VP4 genetic group 1 to 4 strains (data not shown). Taken together, these results suggest that the VP4 genetic groups of 16 of 16 well-characterized (excluding strain AU1) prototype HRV strains can be reliably identified on the basis of the size of the PCR products produced during the second (typing) PCR amplification.
PCR confirmation of gene 4 typing. Additional genetic group-specific primer pairs (one plus-sense and one minussense primer for each pair) were selected for each genetic group for cases in which confirmation of a typing reaction was needed. Since some of these primer pairs interfere with each other when they are used as a cocktail, they were used separately in PCRs, starting with HRV dsRNA as a template (i.e., confirmation is a one-step reverse transcription and PCR amplification procedure). To summarize these results, primer pairs iC-1 and 1C-2, 2C-1 and 2C-2, 3C-1 and 3C-2, and 4C-1 and 4C-2 (specific for genetic groups 1, 2, 3, and 4, respectively) specifically reverse transcribe and amplify dsRNA of HRV strains from VP4 genetic groups 1 to 4, respectively, to yield 180-, 504-, 206-, and 261-bp products (Fig. 4, A to D, respectively) . Although strain WI61 did not produce a specific product in the experiment (Fig. 4A, lane  8) , we confirmed that primer pairs iC-1 and 1C-2 can specifically reverse transcribe and amplify dsRNA from partially purified WI61 virus particles (data not shown).
Gene 4 typing of HRV in stool samples. To study the diversity of gene 4 types in circulating strains of HRV, we first developed a method to improve the extraction of dsRNA from stool samples. Recent experience with our previous methods demonstrated that some specimens amplified poorly; we believed that this was due to inhibitors of reverse transcriptase that were present in the stool samples (11) . A recent report (33) described the use of glass powder for RNA extraction and suggested that inhibitors in stool could be reduced or eliminated by its use (33) . Several types of glass powder, ISOGENE, GENECLEAN II, and RNAID, are commercially available (33, 34 (11) because phenol-chloroform extraction was not necessary and it was more sensitive. Using RNAID with the two-step gene 4 typing method, we could detect dsRNAs from as few as 1,000 Wa (VP4-genetic group 1), 1,000 DS1 (group 2), 10 M37 (group 3), or 1,000 K8 (group 4) virus particles pipetted into a stool specimen (Fig. 5) .
To determine whether the stool extraction and gene 4 typing methods had utility for diverse strains of circulating HRV, we analyzed several sets of samples from the United States, Mexico, Costa Rica, and Venezuela. Of the eight VP7 serotype 2 samples from Costa Rica (Fig. 6 ) that were reverse transcribed and amplified with con 3 and con 2 (Fig.  6A, lanes 6 to 13) , seven had visible products (Fig. 6A , lanes 6 to 10 and 12) (although they are not visible in Fig. 6A , a product was faintly visible in lane 11 of the original photograph [data not shown]). Products of 876 bp were found in all four positive control dsRNAs from VP4 genetic groups 1 to 4 (Fig. 6A, lanes 1 to 4) , but not in a known rotavirusnegative stool sample (Fig. 6A, lane 5) . When portions of these dsDNAs were subjected to gene 4 typing by PCR (Fig.  6B, lanes 6 to 13) , seven of the eight Costa Rican samples produced dsDNA products (Fig. 6B, lanes 6 to 10, 12 ) (although they are not visible in Fig. 6B , a product was faintly visible in lane 11 of the original photograph [data not shown]), all of which comigrated with the genetic group 2-positive control (Fig. 6B, lane 2; 483-bp dsDNA) . Of the eight samples that were positive for genetic group 2 in the typing reaction, five were confirmed by the production of a 504-bp product (Fig. 6C, lanes 7 to 10 and 12) , and one additional genetic group 2-positive sample was obtained in a repeat experiment by using confirmation primers 2C-1 and 2C-2.
We also validated the method described here for stool samples containing rotaviruses with VP7 serotype 1 specificity (from ill children in the United States) and for specimens containing rotaviruses with VP7 serotype 1 or 4 specificity (from newborn infants in a Venezuelan hospital neonatal ward) (17) (gene 4 typing results for U.S. children and Venezuelan infants are shown in Fig. 7 and 8 , respectively). In total (Table 2) , we analyzed 50 samples, and 47 were positive by PCR. We found that, with one exception, strains with VP7 serotype 1 specificity were from VP4 genetic group 1, whereas all of the VP7 serotype 2 isolates were from genetic group 2. The lone exception to this pattern, excluding isolates from infants in neonatal wards (i.e., the Venezuelan isolates), was a VP7 serotype 1 isolate from Mexico, which contained a genetic group 3 gene 4. Among the 14 known (eight VP7 serotype 1 and 6 VP7 serotype 4) strains from Venezuela that caused asymptomatic infections, all but 1 (which was negative by PCR) were from VP4 genetic group 3, which is in agreement with the results of a hybridization study previously conducted with these isolates (17) . The few samples (3 of 50) that were antigen positive but negative by PCR (using at least two different pairs of primers) were not analyzed further. The samples in lanes 1 to 13 were reverse transcribed and amplified with a primer pair specific for gene 4 type 2, and the products were analyzed as described in the legend to Fig. 2 (9) . Evidence that this region of VP4 (the VP8 cleavage fragment) contains the antigenic sites involved in delineating VP4 serotypes has also been presented (10) . As for the hypervariable regions of genes 7 to 9, which are responsible for delineating VP7 serotypes (15) , the comparable regions of gene 4 are highly conserved among HRV strains in the same VP4 genetic group and, thus, are wellsuited for selecting group-specific PCR primers.
The method described here is highly specific, in that the genetic groups of 16 well-characterized HRV strains could be reliably identified. Likewise, the sensitivity of the method is very high. With the typing primers for which we had sensitivity data, we could obtain a positive typing reaction with the dsRNA from as few as 10 to 1,000 virus particles (this sensitivity is 500 to 50,000 times more sensitive than that obtained by using ROTACLONE, a commercial EIA, and about 200 to 20,000 times greater than that of a recently reported hybridization method for gene 4 typing [17] ). Thus, PCR typing may be advantageous in samples with < 108 virus particles per ml of stool extract.
Gene 4 typing offers several other important benefits. First, on the basis of the observation that all members of a VP4 genetic group (from nucleotide and deduced amino acid sequence conservation) can be classified into the same VP4 antigenic group (10) and in the absence of immunologic methods (either MAb-or polyclonal antibody-based tests) to study the antigenic diversity of VP4, gene 4 typing by PCR and a recently reported hybridization method for the same purpose (17) serve as valid proxy methods to assess VP4 diversity. Although the VP4 proteins of genetic group 1 to 4 strains can be distinguished by cross-neutralization tests with antisera to VP4 or VP8 polypeptides that are expressed (10, 18) , these tests are too cumbersome for studying VP4 diversity in field isolates, and MAbs that are able to distinguish the known VP4 antigenic types have yet to be isolated.
Second, in conjunction with recently described PCR (12) , hybridization (17) and EIA (31) methods for use in the identification of VP7 serotype specificity, gene 4 typing will permit us to more fully characterize the diversity of both HRV neutralization antigens before MAbs with new VP4 and VP7 specificities become available.
Our initial results indicate that HRV isolates from two epidemiologically important VP7 serotypes (serotypes 1 and 2) from several parts of the world possess almost exclusively gene 4 types 1 and 2. This finding was not unexpected, since gene 4 types 1 and 2 have been identified (by nucleotide sequencing) only in prototype strains with VP7 serotype 1, 3, and 4 (type 1) and VP7 serotype 2 (type 2) specificities. In another recent study in which a hybridization method was used, type 1 gene 4 was identified in strains with VP7 serotype 3, 4, and 9 specificities (>50% of the total number of samples with typeable gene 4's) and type 2 gene 4 was identified in strains with VP7 serotype 2 specificity (about 20% of the total) (28) . Taken together, these results suggest that strains with VP4 serotype 1A and 1B specificities (type 1 and 2 gene 4's) are predominant strains in many areas of the world. A single isolate with a type 3 gene 4 and VP7 serotype 1 specificity was identified in an asymptomatic Mexican infant who excreted rotavirus. Such strains (frequently designated neonatal or asymptomatic rotaviruses) have been isolated almost exclusively from newborn infants in neonatal wards, are shed asymptomatically, can belong to VP7 serotypes 1 to 4, and share a highly conserved gene 4 that has been postulated to account for their avirulent phenotype (9) . All other isolates containing type 3 gene 4's identified in this study were from infants in neonatal wards (Table 2 ). It will be interesting to determine the frequency with which these strains occur in subjects with symptomatic infections, and in this regard, several isolates with type 3 gene 4's have recently been identified in neonates or older infants with gastroenteritis (28) . The other two gene 4 types (types 4 and 5) occur in strains that have been isolated only rarely (2, 21, 29) . Gene 4 typing will permit us to better assess the frequency and distribution of gene 4 types and to determine whether they occur in strains with various VP7 serotype specificities. In a recent study (28) , strains with a type 5 gene 4 and VP7 serotype 1, 3, 6, and 8 specificities have been identified at a low frequency (<10% of total typed samples) in HRV isolates from several countries, suggesting that reassortment may contribute to antigenic diversity in these strains, as observed previously for rotaviruses with VP4 serotype 1A and 2 specificities (10).
The need for a dual serotyping system for II4RV VP4 and VP7 was suggested several years ago (13) . Recent studies on the genetic and antigenic diversities of HRV VP4 have confirmed the need for a VP4 classification system (10, 18) , but the several different terminologies which have arisen to describe the genetic and antigenic specificities attributed to VP4 and VP7 (9, 10, 30) have resulted in some confusion in this field. We support the adoption of the proposed binary nomenclature system for rotavirus serotyping. The system designates the antigenic specificities attributed to VP7 as G types and those attributed to VP4 as P types (30) .
